return equiti ttm
posit outlook continu execut keep stori
thursday august report third-quart result
show good overal balanc portfolio excel work margin expans
manag reiter posit theme trend heard mani time
bd emphasi integr margin expans top-lin appear
healthi across three key segment continu appreci predict natur
diversifi product offer cash flow gener organ abl deliv
quarter quarter base third-quart call see reason stray
thesi bd deliv midsingle-digit revenu growth midteen ep growth next
sever year combin impress cash flow gener offer low-beta steadi
return option investor
term stock reaction believ stock thursday due big
run print expect begun build regard revenu upsid given
compani medic technolog said feel like gener may
becom bit softer later period entir industri addit
time help bd fiscal fourth quarter
revenu billion compar fxn includ bard prior period
exclud divestitur adjust hurrican impact dispens chang
beat target billion million versu model saw
upsid bioscienc million medic manag solut million
medic deliveri solut million peripher intervent million
preanalyt system million saw downsid diabet million
surgeri million urolog critic million pharmaceut system
million diagnost system million time hit compani basi
non-gaap ep report fxn beat estim
ep upsid driven sale volum gross margin net incom
share outstand higher tax rate higher oper expens off-set
gain oper margin expans basi point perform notabl
indic solid oper perform integr benefit compani
found compani repres collect establish franchis gener
solid cash focu oper effici compani well diversifi three main segment
medic revenu life scienc intervent bd dozen product line make
compani focus conglomer compani develop innov product address signific
healthcar problem also demonstr valu healthcar worker patient research alik
becton dickinson compani
pleas refer import disclosur page analyst certif page
william blair affili seek busi compani cover research report
result investor awar firm may conflict interest could affect object
report report intend provid person invest advic opinion recommend
herein take account individu client circumst object need intend
recommend particular secur financi instrument strategi particular client recipi
report must make independ decis regard secur financi instrument mention
full-year guidanc rais top line impli legaci bd growth legaci bard
initi rang medic call life scienc call
plu intervent still impli strong number fourth fiscal
quarter ep call midpoint bottom end rang rais
result top-lin upsid specif commentari though believ consensu estim
revenu growth ep growth reason start point
rather go back earn transcript highlight item discuss noth materi
differ expect hear link note wrote come recent c-suit
call ceo vinc forlenza call discuss among topic sever key growth driver
import cultur got mr lenza thought cr bard acquisit progress full transcript
call pleas contact william blair sale repres c-suit call recap upbeat discuss highlight reason
believ promis glori day ahead
year maintain bd excit fastest-grow name list like safest
play given divers segment geograph revenu base manag team know compani
strength weak result could count make solid strateg decis invest
would lead depend result cr bard transact chang busi make-up still see set product
offer combin entiti repres steadi growth opportun becom use bd
appreci fact combin ep growth toward top rang larg cap medic devic base
ep stock trade time see reason qualiti franchis
quarter reviewcurr actualcurr estimateprior year quarterfav/ unfav varianc million unless type bd bd life bd subtot constant foreign currenc total gross oper oper income/ expens earn incom tax effect net incom prefer stock net incom dilut share ep share adj pref ep post pref consensu estim currentrevenu earn per sourc william blair compani estim compani report factsetfav/ unfav varianc william blair
model chang million unless notedprevi estimatechangecurr guidancecurr estimaterevenu segment fxn guidanc bd bd life bd subtot constant foreign currenc total growth/ declin bp growth/ declin bp compar fxn bp gross bp oper oper bp income/ expens earn incom tax effect bp net incom prefer stock net incom dilut share ep cash basi post pref consensu estim revenu earn per sourc william blair compani estim compani report factset import disclosur
